Literature DB >> 18157385

Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency.

Teresa C Vieira1, Valter T Boldarine, Julio Abucham.   

Abstract

UNLABELLED: Combined Pituitary Hormone Deficiency (CPHD) is a prevalent disease in Neuroendocrinology services. The genetic form of CPHD may originate from mutations in pituitary transcription factor (PTF) genes and the pituitary image in these cases may give a clue of what PTF is most probably mutated: defects in LHX4 are usually associated with ectopic posterior pituitary (EPP); defects in LHX3, PIT1, and PROP1, with normally placed posterior pituitary (NPPP); HESX1 mutations are associated with both.
OBJECTIVE: To identify mutations in PTF genes in patients with idiopathic hypopituitarism followed in our service, based on the presence or absence of EPP on sellar MRI.
METHODS: Forty patients with idiopathic hypopituitarism (36 families, 9 consanguineous), followed in the Neuroendocrinology Outpatient Clinic of UNIFESP, Brazil, were submitted to sequencing analyses of PTF genes as follows: LHX3, HESX1, PIT1, and PROP1 were sequenced in patients with NPPP (26/40) and HESX1 and LHX4 in patients with EPP (14/40).
RESULTS: We identified only PROP1 mutations in 9 out of 26 patients with CPHD and NPPP (35%). Since eight of them came from 4 consanguineous families, the prevalence of PROP1 mutations was higher when only consanguineous families were considered (44%, 4/9). At the end of the study, we decided to sequence PROP1 in patients with EPP, just to confirm that they were not candidates for PROP1 mutations. No patients with EPP had PROP1 or other PTF mutations.
CONCLUSIONS: Patients with idiopathic CPHD and NPPP, born from consanguineous parents, are the strong candidates for PROP1 mutations. Other developmental gene(s) may be involved in the genesis of idiopathic hypopituitarism associated with EPP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18157385     DOI: 10.1590/s0004-27302007000700012

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  13 in total

Review 1.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

2.  Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency.

Authors:  Helena Filipsson Nyström; Alexandru Saveanu; Edna J L Barbosa; Anne Barlier; Alain Enjalbert; Camilla Glad; Jenny Palming; Gudmundur Johannsson; Thierry Brue
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

3.  Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study.

Authors:  Firdevs Baş; Z Oya Uyguner; Feyza Darendeliler; Zehra Aycan; Ergun Çetinkaya; Merih Berberoğlu; Zeynep Şiklar; Gönül Öcal; Şükran Darcan; Damla Gökşen; Ali Kemal Topaloğlu; Bilgin Yüksel; Mehmet Nuri Özbek; Oya Ercan; Olcay Evliyaoğlu; Semra Çetinkaya; Yaşar Şen; Emre Atabek; Güven Toksoy; Banu Küçükemre Aydin; Rüveyde Bundak
Journal:  Endocrine       Date:  2014-12-11       Impact factor: 3.633

Review 4.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

Review 5.  Combined pituitary hormone deficiency: current and future status.

Authors:  F Castinetti; R Reynaud; M-H Quentien; N Jullien; E Marquant; C Rochette; J-P Herman; A Saveanu; A Barlier; A Enjalbert; T Brue
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

6.  SCREENING OF PROP-1, LHX2 AND POU1F1 MUTATIONS IN PATIENTS WITH ECTOPIC POSTERIOR PITUITARY GLAND.

Authors:  H A Korkmaz; U Karaarslan; C Eraslan; D Atila; F Hazan; V Barışık; E S Ata; O Etlik; M Yıldız; B Ozkan
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

7.  Combined pituitary hormone deficiency due to gross deletions in the POU1F1 (PIT-1) and PROP1 genes.

Authors:  Eleonore Bertko; Jürgen Klammt; Petra Dusatkova; Mithat Bahceci; Nazli Gonc; Louise Ten Have; Nurgun Kandemir; Georg Mansmann; Barbora Obermannova; Wilma Oostdijk; Heike Pfäffle; Denise Rockstroh-Lippold; Marina Schlicke; Alpaslan Kemal Tuzcu; Roland Pfäffle
Journal:  J Hum Genet       Date:  2017-03-30       Impact factor: 3.172

8.  Congenital hypopituitarism: how to select the patients for genetic analyses.

Authors:  Giuseppe Crisafulli; Tommaso Aversa; Giuseppina Zirilli; Filippo De Luca; Romina Gallizzi; Malgorzata Wasniewska
Journal:  Ital J Pediatr       Date:  2018-04-06       Impact factor: 2.638

Review 9.  Genetic regulation of pituitary gland development in human and mouse.

Authors:  Daniel Kelberman; Karine Rizzoti; Robin Lovell-Badge; Iain C A F Robinson; Mehul T Dattani
Journal:  Endocr Rev       Date:  2009-10-16       Impact factor: 19.871

10.  Clinical spectrum of hypopituitarism in India: A single center experience.

Authors:  Abhay Gundgurthi; M K Garg; Reena Bhardwaj; Karninder S Brar; Sandeep Kharb; Aditi Pandit
Journal:  Indian J Endocrinol Metab       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.